Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Francisco Gómez, Veiga"'
Autor:
Jesús Calleja-Escudero, Víctor Barrondo, Andrés Rodriguez-Alonso, Francisco Gómez-Veiga, Joan Bestard, Antonio Gómez-Caamaño, Anne-Sophie Grandoulier, Maria Pérez-Sampietro, Venancio Chantada-Abal, Raúl Poza de Celis, on behalf of ANAREN Study Group
Publikováno v:
Drugs in Context, Iss 13, Pp 1-12 (2024)
Introduction: Injectable extended-release formulations of luteinizing hormone-releasing hormone agonists (LHRHa) have simplified the treatment of prostate cancer with a satisfactory level of androgen castration. This study aims to determine the perce
Externí odkaz:
https://doaj.org/article/fc179a6ee86b4f4bbad25c0183770cca
Autor:
Juan, Morote, Antonio, Gómez-Caamaño, Raúl Poza, de Celis, Francisco, Gómez-Veiga, Juan P, Ciria, Jesús, Calleja, Javier, Extramiana, Maria, Pérez-Sampietro, Valerie, Perrot, Javier C, Angulo
Publikováno v:
Scientia
Androgen deprivation; Hormonal therapy; Radiotherapy Privación de andrógenos; Terapia hormonal; Radioterapia Privació d'andrògens; Teràpia hormonal; Radioteràpia Aims To estimate the prevalence of lower urinary tract symptoms (LUTS) in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2874e5fe9280f5916846248874d1229f
https://doi.org/10.1002/nau.25031
https://doi.org/10.1002/nau.25031
Autor:
Javier C. Angulo, José L. Álvarez-Ossorio, José L. Domínguez-Escrig, José L. Moyano, Alejandro Sousa, Jesús M. Fernández, Francisco Gómez-Veiga, Miguel Unda, Joaquín Carballido, Victor Carrero, Tomás Fernandez-Aparicio, Ángel García de Jalón, Eduardo Solsona, Brant Inman, Joan Palou
Publikováno v:
European urology oncology.
Optimising therapeutic strategies of intermediate-risk non-muscle-invasive bladder cancer (IR-NMIBC) is needed.To compare recurrence-free survival (RFS) with adjuvant intravesical mitomycin C (MMC) at normothermia or hyperthermia using the COMBAT bla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618759d4e6ed484665ea0abd04149fa1
https://pubmed.ncbi.nlm.nih.gov/36435738
https://pubmed.ncbi.nlm.nih.gov/36435738
Autor:
Sara Marcos, Asensio, Álvaro Julio, Virseda Rodríguez, María Manuela, Martín Izquierdo, Manuel, Herrero Polo, Mónica Paola, Coderque Mejía, Alberto, Rocha de Lossada, Sara, Hinchado Morgado, Andrea, Noya Mourullo, Francisco, García Gómez, Teresa, Hernández Sánchez, Patricia, Antúnez Plaza, Javier, García García, Javier, Martín-Vallejo, Francisco, Gómez Veiga
Publikováno v:
Archivos espanoles de urologia. 74(5)
VA is currently considered the treatment of choice for patients with low and very low risk prostate cancer. We analyzed the evolution of this treatment strategy in our series and adherence to the protocol.Ambispective study of patients in VA in our c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5845d35f6eba77c9ef40df09c8437e25
https://pubmed.ncbi.nlm.nih.gov/34080567
https://pubmed.ncbi.nlm.nih.gov/34080567
Autor:
Víctor Zamora, Olatz Garin, Yolanda Pardo, Àngels Pont, Cristina Gutiérrez, Patricia Cabrera, Francisco Gómez-Veiga, José Ignacio Pijoan, Mark S. Litwin, Montse Ferrer, Montse Ventura, Ferran Guedea, Ferran Ferrer, Ana Boladeras, Andrea Slocker, José Francisco Suárez, Manuel Castells, Xavier Bonet, David B. Delgado, MaJosé Ortiz, Ismael Herruzo, José López-Torrecilla, Jorge Pastor, Víctor Muñoz, Patricia Willsich, Marisa Vázquez, Àlvar Roselló, Arantxa Eraso, Carlos Ferrer, Ángel Sánchez, Víctor Macías, Lluís Fumadó, Josep Jové, Moisés Mira, Elena Villafranca, Juan Morote, Ana Celma, Pilar Samper, Luís A. Glaría, MaÁngeles Cabeza, Germán Juan, Samuel Méndez Ramírez, Amalia Palacios, Amelia Béjar, Sonia Garcia, Sebastà Sabater
Objectives This study aimed to develop mapping algorithms from the Expanded Prostate Cancer Index Composite (EPIC) and the Short-Form (SF) Health Surveys to the Patient-Oriented Prostate Utility Scale (PORPUS), an econometric instrument specifically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6724b10165bf4a9ffe15a2c58a817599
http://hdl.handle.net/10230/53731
http://hdl.handle.net/10230/53731
Autor:
Kurt Miller, Anup Patel, Lars Edenbrandt, Andrea Tubaro, Anders Bjartell, Teuvo L.J. Tammela, Per Wollmer, Wim P.J. Witjes, Manfred P. Wirth, Peter F.A. Mulders, Ola Thorsson, Mattias Ohlsson, Christien Caris, Frans M.J. Debruyne, Francisco Gómez Veiga, Mariana Reza, Elin Trägårdh, Virgilio Cicalese
Publikováno v:
European Urology Oncology, 4, 49-55
European Urology Oncology, 4, 1, pp. 49-55
European Urology Oncology, 4, 1, pp. 49-55
Contains fulltext : 233937.pdf (Publisher’s version ) (Closed access) BACKGROUND: Owing to the large variation in treatment response among patients with high-risk prostate cancer, it would be of value to use objective tools to monitor the status of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f534f505407e2dbc8d6597545f711f
https://doi.org/10.1016/j.euo.2019.05.002
https://doi.org/10.1016/j.euo.2019.05.002
Autor:
Álvaro Julio, Virseda-Rodríguez, Sara, Marcos Asensio, Juan Jesús, Núñez-Otero, Fructuoso, García, Alejandro, Sanz, Emilio, Gutiérrez, José María, Serrano, Sebastián, Valverde, Carlos, Polo, José Heriberto, Amón-Sesmero, Verónica, Rodríguez, Ramón, Cortiñas, Jesús, Calleja, Miguel, Adriazola, Lucía, Gala, Raul, Bermúdez, Ignacio, Moya, Ryszard, Szczesniewski, Miguel Ángel, López-Aramburu, Francisco, Gómez-Veiga
Publikováno v:
Archivos espanoles de urologia. 72(5)
To evaluate the current clinical practice for patients with Prostate Cancer (CP) in the Health Areas of Castilla y León (CyL) in 2014. METHODS: A retrospective multicenter study was designed to provide data on the diagnosis and treatment of PC in Cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbc6ab6b691ca4db3d0f8138d43fcc58
https://pubmed.ncbi.nlm.nih.gov/31223124
https://pubmed.ncbi.nlm.nih.gov/31223124
Autor:
Francisco Gómez Veiga, Wolfgang Warnack, Marek Salagierski, Raj Persad, Erik B. Cornel, Beatriz Lopez, Bertrand Tombal, Henri Bensadoun, Edwina Baskin-Bey, Jan Schraml, Claude Schulman, Vsevolod Matveev, Teuvo L.J. Tammela
Publikováno v:
European urology, 69 (4
Background Intermittent androgen deprivation (IAD) has received increasing attention; however, the current literature is still limited, especially in nonmetastatic prostate cancer (PCa), and the relative efficacy and safety benefits of IAD versus con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b06e54b5662d7412f64f5ecea3f73c25
https://doi.org/10.1016/j.eururo.2015.10.007
https://doi.org/10.1016/j.eururo.2015.10.007
Publikováno v:
Archivos espanoles de urologia. 71(3)
The therapeutic range in advanced and castration resistant prostate cancer is widening. Therapies must offer real clinical efficacy, and they also should be acceptable and desirable for patients, specially in advanced disease. We analyze the value of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2dbb941b0b8d538a5533195c4c23d18d
https://pubmed.ncbi.nlm.nih.gov/29633952
https://pubmed.ncbi.nlm.nih.gov/29633952
Autor:
Jose Luis Alvarez-Ossorio, Jacques Planas, Juan J Lobato, José A. Lorente, Francisco Gómez Veiga, Daniel Pesqueira, Antonio Gómez-Caamaño, Maria J. Ribal, Juan Morote, Angel Tabernero, Mariano Porras
Publikováno v:
Journal of Urology. 193:1963-1969
Purpose Androgen deprivation therapy may promote the development of the metabolic syndrome in patients with prostate cancer. We assessed the prevalence of the full metabolic syndrome and its components during the first year of androgen deprivation th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c9894b3e0e5eceee9018b8b809d377f
https://doi.org/10.1016/j.juro.2014.12.086
https://doi.org/10.1016/j.juro.2014.12.086